Developing Risk Prediction Model and Testing the Effect of Dual Task Walking on Improving Cognitive Function in Patients With Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- Behavioral: dual-task walking
- Registration Number
- NCT04490733
- Lead Sponsor
- National Taiwan University Hospital
- Brief Summary
The aims of this three-year study are to explore cognitive function under different stages of colorectal cancer (CRC) and its related factors; and understand its disturbance and coping process caused by cancer-induced cognitive impairment (CICI) from patient perspective; and further to test effect of dual-task walking on improving cognitive function in CRC patients.
- Detailed Description
Developing risk prediction model of mild cognitive impairment in patients with colorectal cancer from active treatment to survivor by exploring the effect of surgery and chemotherapy on CICI, and to identify high risk population; and testing the effect of dual-task walking on improving cognitive function (memory, executive function and attention) in CRC patients.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 355
- Patients with newly diagnosed stage I to III colorectal cancer and Montreal Cognitive Assessment (MoCA) < 24.
- Patients with cancer other than colorectal cancer or have cancer recurrence.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Experimental group dual-task walking Participants in the experimental group will receive 3 times interventions during 10th to 12th course of chemotherapy and 12 weekly phone-call to assess effect and barriers of dual-task walking.
- Primary Outcome Measures
Name Time Method Neuropsychological battery test Change from baseline cognitive function at 12 months Five neuropsychological battery tests will be used to assess cognitive function of memory
Self-report Questionnaire Change from baseline cognitive function at 12 months The questionnaire includes 37 items to assess perceived cognitive function
- Secondary Outcome Measures
Name Time Method Self-report Questionnaire Change from baseline symptom at 12 months The questionnaire includes 24 items to assess symptom severity
Trial Locations
- Locations (1)
National Taiwan University
🇨🇳Taipei, Taiwan